AU Patent

AU2003267732A1 — Gabapentin tablets and methods for their preparation

Assigned to Ranbaxy Laboratories Ltd · Expires 2004-05-04 · 22y expired

What this patent protects

Patent listed against Brilinta.

Drugs covered by this patent

Patent Metadata

Patent number
AU2003267732A1
Jurisdiction
AU
Classification
—
Expires
2004-05-04
Drug substance claim
No
Drug product claim
No
Assignee
Ranbaxy Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.